We have eagerly awaited seeing the actual results since the sponsor company (Novo Nordisk) issued a press release in August that proclaimed a 20% relative reduction of cardiovascular death, heart attack or stroke, the primary endpoint of the trial
Those with severe kidney disease should also use berberine cautiously and under medical supervision, as specific guidance is limited given berberine's status as a supplement rather than a regulated pharmaceutical
Increasing your physical activity and eating more fiber can help with constipation
The choice between injection and pill depends on which medicine is prescribed, personal preference, and overall health needs
How long does it take for semaglutide GLP-1 to show weight loss effects
Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year